Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Belani

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Seminars in Oncology|April 6, 1999
Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancerC P Belani
Seminars in Oncology|August 1, 1993
Multimodality management of regionally advanced non-small-cell lung cancerC P Belani
Clinical Lung Cancer|November 5, 2003
Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapyChandra P Belani
Clinical Lung Cancer|December 9, 2003
Lung cancer: search for a markerC P Belani
Clinical Lung Cancer|January 15, 2004
Newer cytotoxic and targeted agents are advancing the treatment of lung cancerChandra P Belani
Clinical Lung Cancer|January 21, 2004
Non-small-cell lung cancer have we reached a "chemotherapy efficacy plateau"?C P Belani
Clinical Lung Cancer|January 11, 2005
Emerging advances in the management of lung cancerChandra P Belani
Clinical Lung Cancer|August 18, 2004
Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancerChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|March 23, 2006
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxelChandra P Belani
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancerC P Belani
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Seminars in Oncology|April 6, 1999
Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancerC P Belani
Seminars in Oncology|August 1, 1993
Multimodality management of regionally advanced non-small-cell lung cancerC P Belani
Clinical Lung Cancer|November 5, 2003
Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapyChandra P Belani
Clinical Lung Cancer|December 9, 2003
Lung cancer: search for a markerC P Belani
Clinical Lung Cancer|January 15, 2004
Newer cytotoxic and targeted agents are advancing the treatment of lung cancerChandra P Belani
Clinical Lung Cancer|January 21, 2004
Non-small-cell lung cancer have we reached a "chemotherapy efficacy plateau"?C P Belani
Clinical Lung Cancer|January 11, 2005
Emerging advances in the management of lung cancerChandra P Belani
Clinical Lung Cancer|August 18, 2004
Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancerChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|March 23, 2006
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxelChandra P Belani
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancerC P Belani
Pageof 30